These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100 [TBL] [Abstract][Full Text] [Related]
7. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies. Odolczyk N; Zielenkiewicz P Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712 [TBL] [Abstract][Full Text] [Related]
8. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology. Clunes MT; Boucher RC Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723 [TBL] [Abstract][Full Text] [Related]
9. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088 [TBL] [Abstract][Full Text] [Related]
10. Developmental paradigm for early features of cystic fibrosis. Larson JE; Cohen JC Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy. Kerem E Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796 [TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis and related diseases of the pancreas. Naruse S; Kitagawa M; Ishiguro H; Fujiki K; Hayakawa T Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):511-26. PubMed ID: 12079272 [TBL] [Abstract][Full Text] [Related]
19. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease. Pasyk S; Li C; Ramjeesingh M; Bear CE Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216 [TBL] [Abstract][Full Text] [Related]
20. Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start. Elborn JS Thorax; 2012 Jan; 67(1):4-5. PubMed ID: 22058188 [No Abstract] [Full Text] [Related] [Next] [New Search]